William D. Clark

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Marc Banjak, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William D. Clark:

Company Role Class Num Shares Value Price $ Report Date Ownership
GENOCEA BIOSCIENCES, INC. President and CEO, Director Common Stock 304,377 $380,471 $1.25 02 Jun 2022 Direct
iBio, Inc. Director Common Stock 1,838 $4,999 $2.72 10 Jan 2025 Direct
Aldeyra Therapeutics, Inc. Director Stock Option (Right to Buy) 76,760 17 Apr 2025 Direct
iBio, Inc. Director Stock Option (right to buy) 13,500 20 Nov 2025 Direct

Insider Reports Filed by William D. Clark

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IBIO iBio, Inc. 20 Nov 2025 1 $0 4 Director 24 Nov 2025, 16:09
ALDX Aldeyra Therapeutics, Inc. 17 Apr 2025 1 $0 4 Director 18 Apr 2025, 16:41
ALDX Aldeyra Therapeutics, Inc. 17 Apr 2025 0 $0 3 Director 18 Apr 2025, 16:21
IBIO iBio, Inc. 10 Jan 2025 1 $4,999 4 Director 13 Jan 2025, 16:31
IBIO iBio, Inc. 21 Nov 2024 1 $0 4 Director 25 Nov 2024, 16:32
GNCA GENOCEA BIOSCIENCES, INC. 02 Jun 2022 1 -$241 4 President and CEO, Director 03 Jun 2022, 16:11
GNCA GENOCEA BIOSCIENCES, INC. 31 May 2022 1 -$7,233 4 President and CEO, Director 02 Jun 2022, 16:31
GNCA GENOCEA BIOSCIENCES, INC. 04 Apr 2022 1 -$4,905 4 President and CEO, Director 05 Apr 2022, 08:15
GNCA GENOCEA BIOSCIENCES, INC. 15 Mar 2022 3 -$12,578 4 President and CEO, Director 17 Mar 2022, 16:06
GNCA GENOCEA BIOSCIENCES, INC. 31 Dec 2021 2 -$14,920 5 President and CEO, Director 16 Mar 2022, 17:28
IBIO iBio, Inc. 09 Dec 2021 1 $0 4 Director 13 Dec 2021, 18:12
IBIO iBio, Inc. 23 Aug 2021 1 $0 4 Director 25 Aug 2021, 20:31
IBIO iBio, Inc. 23 Aug 2021 0 $0 3 Director 25 Aug 2021, 20:30